Performance of XBI SPDR S&P Biotech | 3.4% in 12m
Compare XBI with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare SPDR S&P Biotech with its related Sector/Index SPY
Performance Duell XBI vs SPY
| TimeFrame | XBI | SPY |
|---|---|---|
| 1 Day | -0.89% | -0.05% |
| 1 Week | -0.84% | 0.97% |
| 1 Month | -9.42% | -2.76% |
| 3 Months | -4.31% | 4.45% |
| 6 Months | 25.1% | 20.16% |
| 12 Months | 3.37% | 24.26% |
| YTD | -6.97% | 7.26% |
| Rel. Perf. 1m | -0.74 | |
| Rel. Perf. 3m | -0.45 | |
| Rel. Perf. 6m | 0.52 | |
| Rel. Perf. 12m | -1.81 |
Is SPDR S&P Biotech a good stock to buy?
Neither. Based on ValueRay Analyses, SPDR S&P Biotech is currently (April 2024)
neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -0.38 and therefor a neutral rating according to historical growth.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XBI as of April 2024 is 75.08. This means that XBI is currently overvalued and has a potential downside of -10.56%.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XBI as of April 2024 is 75.08. This means that XBI is currently overvalued and has a potential downside of -10.56%.
Is XBI a buy, sell or hold?
SPDR S&P Biotech has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of 3.37%.
In compare to SPDR S&P 500 Trust, XBI made -20.89% less over the last 12 months. Due to the underperformance, it is recommend to sell XBI.
In compare to SPDR S&P 500 Trust, XBI made -20.89% less over the last 12 months. Due to the underperformance, it is recommend to sell XBI.
Values above 0%: XBI is performing better - Values below 0%: XBI is underperforming
Compare XBI with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.81% | -6.66% | 4.98% | -20.89% |
| US NASDAQ 100 | QQQ | -1.00% | -5.32% | 5.92% | -32.53% |
| US Dow Jones Industrial 30 | DIA | -2.80% | -7.31% | 8.06% | -12.32% |
| German DAX 40 | DBXD | -2.61% | -8.38% | 3.66% | -9.97% |
| UK FTSE 100 | ISFU | -3.02% | -9.53% | 12.10% | -1.89% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.64% | -8.80% | 25.44% | 18.18% |
| Hongkong Hang Seng | HSI | -6.64% | -7.83% | 31.98% | 24.41% |
| Japan Nikkei 225 | EXX7 | -0.71% | -3.14% | 8.15% | -15.17% |
| India NIFTY 50 | INDA | -2.88% | -12.33% | 6.26% | -26.29% |
| Brasil Bovespa | EWZ | -3.56% | -5.51% | 18.99% | -14.02% |
XBI SPDR S&P Biotech vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.94% | -8.56% | 5.04% | -38.21% |
| Consumer Discretionary | XLY | -1.92% | -5.07% | 11.20% | -15.76% |
| Consumer Staples | XLP | -4.32% | -10.08% | 11.32% | 1.72% |
| Energy | XLE | -3.03% | -12.56% | 13.32% | -11.97% |
| Financial | XLF | -4.44% | -9.08% | -3.59% | -22.92% |
| Health Care | XLV | -2.59% | -6.40% | 13.90% | -2.65% |
| Industrial | XLI | -1.65% | -7.56% | 0.73% | -19.72% |
| Materials | XLB | -0.10% | -6.07% | 6.64% | -7.59% |
| Real Estate | XLRE | -3.39% | -4.66% | 11.75% | 1.03% |
| Technology | XLK | -0.43% | -4.39% | 4.85% | -32.34% |
| Utilities | XLU | -4.99% | -13.44% | 10.05% | 4.70% |
| Aerospace & Defense | XAR | -2.76% | -6.47% | 6.78% | -13.69% |
| Biotech | XBI | - | - | - | - |
| Homebuilder | XHB | -2.68% | -3.11% | -20.07% | -45.34% |
| Retail | XRT | -3.47% | -4.17% | 0.46% | -14.11% |
Does SPDR S&P Biotech outperform its market, is XBI a Sector Leader?
No, over the last 12 months SPDR S&P Biotech (XBI) made 3.37%, while its related Sector, the SPDR S&P 500 Trust (SPY) made 24.26%.
Over the last 3 months XBI made -4.31%, while SPY made 4.45%.
No, over the last 12 months SPDR S&P Biotech (XBI) made 3.37%, while its related Sector, the SPDR S&P 500 Trust (SPY) made 24.26%.
Over the last 3 months XBI made -4.31%, while SPY made 4.45%.
| Period | XBI | SPY | S&P 500 |
|---|---|---|---|
| 1 Month | -9.42% | -2.76% | -2.76% |
| 3 Months | -4.31% | 4.45% | 4.45% |
| 12 Months | 3.37% | 24.26% | 24.26% |